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ORIGINAL ARTICLE

Genomic imbalances in mental retardation
In t r o d u c t i o n : I t h as been estimated th at cy tog enetically v isible rearrang ements are p resent in ,1 % of new borns. Th ese ch romosomal ch ang es can cau se a w ide rang e of deleteriou s dev elop mental ef f ects, inclu ding mental retardation ( M R ) . I t is assu med th at many oth er cases ex ist w h ere th e cau se is a su bmicroscop ic deletion or du p lication. To f acilitate th e detection of su ch cases, dif f erent tech niq u es h av e been dev elop ed, w h ich h av e dif f ering ef f iciency as to th e nu mber of loci and p atients th at can be tested. M e t h o d s : W e imp lemented mu ltip lex amp lif iable p robe h y bridisation ( M A P H ) to test areas k now n to be rearrang ed in M R p atients ( f or ex amp le, su btelomeric/ p ericentromeric reg ions and th ose af f ected in microdeletion sy ndromes) and to look f or new reg ions th at mig h t be related to M R . Re s u l t s : I n th is stu dy , ov er 3 0 0 0 0 screens f or du p lications and deletions w ere carried ou t; 1 6 2 dif f erent loci tested in each of 1 8 8 dev elop mentally delay ed p atients. Th e analy sis resu lted in th e detection of 1 9 rearrang ements, of w h ich ,6 5 % w ou ld not h av e been detected by conv entional cy tog enetic analy sis. A sig nif icant f raction ( 4 6 % ) of th e rearrang ements f ou nd w ere interstitial, desp ite th e f act th at only a limited nu mber of th ese loci h av e so f ar been tested. D i s c u s s i o n : O u r resu lts streng th en th e arg u ments f or w h ole g enome screening w ith in th is p op u lation, as it can be assu med th at many more interstitial rearrang ements w ou ld be detected. Th e streng th s of M A P H f or th is analy sis are th e simp licity , th e h ig h th rou g h p u t p otential, and th e h ig h resolu tion of analy sis. Th is combination sh ou ld h elp in th e f u tu re identif ication of th e sp ecif ic g enes th at are resp onsible f or M R .
T he evolution of the human genome has resulted in a mix ture of large and small intersp ersed and tandem segmental dup lic ations throughout the genome. S uc h dup lic ations p rovide sub strates for homologous rec omb ination, and c onseq uently , the intervening regions show a c onsiderab le rate of rearrangement. 1-3 M any of these rearrangements oc c ur in regions w here a c hange in gene dosage does not affec t human health. H ow ever, after the desc rip tion b y L ej eune of trisomy 2 1 in D ow n' s sy ndrome, 4 and the many sub seq uent p ub lic ations on different aneup loidies, it b ec ame c lear that the genome c ontains many loc i for w hic h the c orrec t c op y numb er is c ritic al for normal develop ment. C hange in genetic dosage of one or more genes is one of the most c ommon c auses of mental retardation ( M R ) . E x amp les of k now n imp ortant loc i inc lude the sub telomeric regions and the areas involved in mic rodeletion sy ndromes. T he sub telomeric regions, loc alised p rox imal to the telomeres, have b een found to b e esp ec ially susc ep tib le to c op y numb er c hanges, ow ing to rep eat ric h seq uenc es that show a high freq uenc y of rec omb ination. 1 I t has b een hy p othesised that ab out 6 % of the p atients w ith idiop athic M R w ill have a sub telomeric rearrangement, 5 a figure c onfirmed in several studies that have rep orted a freq uenc y of 2 -9% of c ry p tic rearrangements in M R p atients. 6 7 T he c ause for M R is only estab lished in ap p rox imately 50 % of c ases, limiting the effic ienc y of genetic c ounselling, detec tion of c arriers, and p renatal diagnosis in these families. T his rather low p erc entage of diagnosis may have several ex p lanations. A routine c y togenetic analy sis gives a minimum resolution of only 4-10 M b . F luoresc ent in situ hy b ridisation ( F I S H ) largely overc omes this limitation of resolution; how ever, it c an only b e ap p lied to simultaneously test a limited numb er of c hromosome regions. F I S H is therefore mostly used to c onfirm w ell rec ognised mic rodeletion sy ndromes in p atients w ho p resent a suggestive p henoty p e. A nother p otential ex p lanation is that the genome c ontains undisc overed loc i that are involved in the aetiology of M R . N ew tec hnologies, suc h as multip lex amp lifiab le p rob e hy b ridisation ( M A P H ) , 8 multip lex ligation dep endent p rob e amp lific ation ( M L P A ) , 9 and array b ased c omp arative genomic hy b ridisation ( array C G H ) , 10 have rec ently b een develop ed to searc h for suc h undisc overed regions. W e c hose to imp lement a high resolution, high throughp ut, rap id, and simp le method, M A P H , 8 w hic h allow s the simultaneous sc reening at the ex on level for c op y numb er c hanges of 40 -50 different c hromosomal loc i in up to 96 p atients in one assay . H ollox et al 11 p reviously desc rib ed sub telomeric sc reening using M A P H of p atients w ith a develop mental delay . I n our study , w e sc reened loc i k now n to b e involved in M R ( sub telomeric / p eric entromeric regions and genes involved in mic rodeletion sy ndromes) as w ell as interstitial genes randomly sp ac ed throughout the genome. A total of 3 0 0 0 0 gene dosage sc reens w ere p erformed from 188 c ases w ith unex p lained develop mental delay that w ere eac h sc anned for c op y numb er c hanges at 16 2 loc i. W e w ere ab le to detec t sub telomeric , p eric entromeric , and interstitial rearrangements in a group of p atients w ith M R and dy smorp hic features and/ or multip le c ongenital ab normalities, as w ell as in p atients selec ted solely on the b asis of develop mental delay . were designed using Prophet (http://www.basic.nwu.edu/ biotools/prophet.html), and supplied by Invitrogen Life Technologies. Products were amplified from genomic DNA by PCR and cloned into the pGEM-T easy vector (Promega). The correct insert was confirmed by sequencing with the B igDye Terminator Cycle Sequencing Ready Reaction kit (Applied B iosystems) at the Leiden Genome Technology Center, using an AB I 3700 Sequencer (Applied B iosystems).
MAPH was performed as described by White et al 12 (see also Leiden Muscular Dystrophy Pages (http://www.dmd.nl/ DMD_ MAPH.html)).
Study population
The DNA of 188 patients (110 males and 78 females) from the Center for Human and Clinical Genetics Leiden (a DNA diagnostic laboratory) was analysed. The patients had been seen by a clinical geneticist or a paediatrician and diagnosed with developmental delay. The study population was divided into two groups. The first group contained 123 coded patients who had been referred for fragile X screening. B efore testing, information about the results of additional tests, such as karyotyping, was not known to the investigators. The second study group (n = 65) was known to have a normal karyotype and had tested negative for fragile X screening. All patients had (multiple) congenital malformations or dysmorphic features in addition to psychological developmental delay.
Data analysis
The data were analysed with GeneScan Analysis and Genotyper Software (Applied B iosystems). These programs provide information about the length, peak height, and peak area of the DNA fragments. Peaks were not used for analysis if they were outside predefined thresholds (upper and lower limits of 12 000 and 150 units, respectively). To obtain a ratio, the height of a given peak was divided by the sum of the heights of the four nearest peaks. As it is not likely that all four probes from diverse regions of the genome are altered in one patient, adding unrelated standards was not necessary in most of the probe sets. For the chromosome 22 probe set, however, unrelated probes, containing sequences from other chromosomes, were used as references.
The median ratio for each probe within a single hybridisation (minimum number of samples 8; maximum number 12) was determined and used to calculate a normalised ratio for each patient. Within each patient, initial ' ' normal'' thresholds were set as 0.75 and 1.25. The standard deviation from the ratios within these limits was calculated, and three times this standard deviation was used as the threshold for any given patient. Any probe that was outside these limits was retested, and samples that showed an apparent copy number change in duplicate were examined further using other techniques. Samples that showed a standard deviation of .10% over probes within the normal thresholds were retested.
Verif ying the MAPH results
Copy number changes detected by MAPH were verified using another technique, primarily FISH with a bacterial artificial chromosome (B AC) or cosmid probe covering the appropriate genomic region. The B ACs used were designed by Flint, 13 or supplied by V ysis Abbott Laboratories (TV , Telvysion, LSI, locus specific identifiers) or selected from the RPCI human B AC library. The FISH experiments were performed following standard operating procedures as described in Dauwerse et al. 14 Some MAPH results were verified using MLPA. 9 
RESULTS
Genotyping
We designed several probe sets covering both the subtelomeric/pericentromeric and interstitial regions, including genes involved in microdeletion syndromes, genes on chromosome 22, and genes spread across all chromosomes (table A, supplemental). The subtelomeric probe set is composed of probes corresponding to the 41 subtelomeric regions, preferably an exon of a gene within 1 Mb from the telomere, five genes near the centromere on the q arm of the acrocentric chromosomes, a sequence in the pseudoautosomal region of chromosome X q and Y q, and an exon of a Y p specific gene. The microdeletion probe set was made up of 27 probes from 21 different genes involved in microdeletion syndromes (Williams, Prader Willi, Angelman, Smith-Magenis, Sotos, 22q11, Alagille, and Wolf-Hirschhorn syndromes). The chromosome 22 probe set included 19 probes from genes on chromosome 22 with approximately 1 Mb spacing. Finally, we used two probe sets containing a total of 68 interstitial genes spread throughout the genome.
We applied these probe sets following two methods of validation. Firstly, a probe was considered to be reliable when the standard deviation over 12 unaffected samples (one hybridisation) was ,15%. Secondly, where possible, we verified the unique and correct localisation of the probes using DNA from patients with known aberrations (42% of the subtelomeric probes, 70% of the microdeletion probes). O verall, 188 patients were screened for deletions and duplications at 162 loci, resulting in the detection of 19 copy number changes. O f these, four aberrations turned out to be cytogenetically visible, namely an isochromosome 18p (karyotype 47, X Y , +i(18p)), a marker chromosome (karyotype 47, X Y , +mar.ish der(22)t(8;22)(q24.1;q11.2)), a triple X female (karyotype 47, X X X ) and a Turner syndrome (karyotype 45, X ), because the outcome of additional investigations had not been made known to the investigators before testing. These patients and their corresponding aberrations were not included in the calculation of the percentage of rearrangements found by MAPH; however, they emphasise the usefulness of MAPH for detecting copy number changes.
In total, eight subtelomeric/pericentromeric rearrangements were found (table 1; upper part). Five of these mutations were detected in the group of MR patients with additional dysmorphic features or additional congenital malformations (5/65 = 7.7%) and the remaining three subtelomeric aneusomies were diagnosed in the group selected on the basis of developmental delay only (3/123 = 2.4%). The smallest mutation found was a deletion of 110 kb maximum present in chromosome band 7p22.3 (table 1, F; and data not shown). Seven rearrangements were interstitial mutations. These are summarised in the lower part of table 1. Where possible, the DNA of both parents of these patients was tested; 75% (9/12) were shown to be de novo. The duplication of 14q11.2 (table 1, O ) and the 7ptel deletion (table 1, F) were also found in the parental DNA, and one of the parents of patient E was a balanced translocation carrier.
As the number of cytogenetically detectable aberrations is highly dependent on the banding resolution, the karyograms of all 15 patients with a MAPH detected rearrangement were re-examined. At a resolution of 500-550 bands per haploid set, the karyograms showed that two subtelomeric copy number changes should have been detected cytogenetically (table 1; A, C). The detection of a 1ptel deletion (table 1, H) was doubtful; however, the duplication of 1ptel (table 1, H) was picked up. This implies that although the presence of the copy number change was known, 63% (12/19) of these genomic changes found in this study were cytogenetically undetectable using karyotyping at a resolution of 500-550 bands.
Case descriptions
Case 1
This 15 year old girl was diagnosed with total anomalous pulmonary venous return, hearing loss in combination with a narrow external auditory meatus, and MR. Physical examination at the age of 14 years showed a short stature (23 SD) and some facial dysmorphic features (small palpebrae, broad mouth, thin upper lip). K aryotyping at a resolution of 400 bands and FISH studies of the 22q11 region did not detect any rearrangements. MAPH study showed a de novo deletion of the subtelomeric region of 18q, which was confirmed by FISH using probe TV18q. The clinical features of this patient are consistent with those of the 18q syndrome phenotype. 15 
Case 2
A male patient, who had previously tested negative for Williams syndrome, was diagnosed with a de novo deletion of 16ptel by MAPH. FISH analysis confirmed this finding and limited the proximal breakpoint to chromosome band 16p13.3, distal to the PKD1-T S C 2 (LocusLink 5310-7249) gene cluster 16 using probe COS15A. As expected, owing to the location of the alphaglobin gene (H B A 1; LocusLink 3039) in this region (16p13.3), 17 further investigation showed that this patient had mild anaemia (alpha thalassaemia heteroz ygosity) in addition to his moderate mental handicap and dysmorphic features. *The rearrangement is probably causative, as a sibling with a similar phenotype has the same aberration. ÀManuscript in preparation. Group of patients`with mental retardation and additional features, 1selected solely on the basis of developmental delay. ôFluorescent in situ hybridisation, **multiplex ligation dependent probe amplification, ÀÀtotal anomalous pulmonary venous return. No/?: one of the parents also has the aberration; however, imprinting, variable expression and low penetrance have not been excluded; TAPV R, total anomalous pulmonary venous return. Cases 1-6 are described in more detail in the text.
Case 3
This boy was seen by a clinical specialist at the age of 2.5 years for his psychomotor retardation and joint hyperflexibility. Physical examination showed few dysmorphic features (a tent shaped mouth), hypotonia, and hypermobility. MAPH analysis revealed a de novo deletion within chromosome band 17p11.2 corresponding to the Smith-Magenis syndrome (SMS) region, using a probe for the DRG2 gene (LocusLink: 1819). The more distally located CO PS3 gene (LocusLink: 8533) showed two copies (fig 1a) . Additional MLPA testing showed that the RAI 1 gene (LocusLink: 10743) was also deleted in this patient (fig 1b) , and FISH analysis (probe LSI-SMS) verified the deletion of part of chromosome band 17p11. 2 (fig 1c) . Recently, three dominant frameshift mutations in RAI 1 have been identified in three patients with phenotypic characteristics of SMS but no cytogenetically detectable deletion of chromosome band 17p11.2. 18 The authors argue that mutations in RAI 1 are responsible for most of the characteristic features of SMS and that further variation is caused by hemizygosity of the other genes in the chromosome region.
Case 4
This male patient showed at the age of 12 years a mild learning disability, a low voice, a disproportionally short stature (height 22 SD, span 23 SD for height, sitting height 20.5 SD, head circumference 22 SD), limited elbow extension, a permanently extended, inflexible fifth digit of both hands with a ram's horn shaped nail and hypotrophy of the hypothenar muscles (fig 2) , and a short broad great toe on both feet. The hand x ray revealed short metacarpals I and V, short distal phalange V, and a delay of bone maturation. In this patient, a de novo deletion of 4q34.1 was detected and confirmed by FISH (probe RP11-475B2). Analysis with a more distally located MAPH probe at chromosome band 4q35.1 showed that this latter region was still present, indicating an interstitial rearrangement. Additional FISH experiments using different BAC probes limited the deletion to a maximum of 3 Mb (data not shown).
Patients with an interstitial 4q deletion have been described with a range of features, depending on the proximal and distal breakpoints of the deletion. 19 As it is known that fifth finger anomalies and short stature are found in patients with an interstitial deletion of 4q including 4q34, 20 as well as in patients with a terminal deletion of 4q, it is possible that the genes responsible for these features are located within this region. 
Figure 2
The right hand of case 4 showing a short, inflexible fifth digit with a ram's horn shaped nail and hypotrophy of the hypothenar muscles.
Case 5
This mildly retarded man, with a de novo duplication within chromosome band 20p12.2, containing the Jagged1 gene (JAG1; LocusLin: 182), died at the age of 60 years from multiple myeloma. He had been institutionalised for over 40 years in a psychiatric hospital because of aggressive behaviour, and was diagnosed as schizophrenic. To the best of our knowledge there has been only one previous report 21 of a duplication of 20p11.21-p11.23, in four members of a family with clinical signs of Alagille syndrome. As our patient is not available for further investigation, it remains unclear whether he had such features.
Case 6
After 41 weeks of gestation, this child was born with a birth weight of 1995 g ((2.5 SD) and a head circumference of 28.5 cm ((2.5 SD). At the age of 25 months, her psychomotor development was severely delayed and she suffered from epilepsy. Physical examination showed growth retardation (length (2 SD; weight 26 SD), microcephaly (head circumference 26 SD), hypertonicity, dystonic movements, facial dysmorphisms (ptosis of the left eye, flat philtrum, thin upper lip; fig 3) ear pits, café au lait spots, and absence of the labia minora. Further investigation revealed corpus callosum hypoplasia and deformed gyri, the presence of only one kidney and mildly increased urinary glutaric acid. U sing the microdeletion probe set, a duplication of 22q11.2 was detected by MAPH, and FISH analysis in interphase nuclei confirmed this finding (LSI TU PLE1). The patient's mother did not carry the duplication, and the father was unavailable for testing. We plan to use polymorphic markers to determine the parental origin of the aberrant chromosome 22.
DISCUSSION
U sing MAPH analysis, we performed a high resolution duplication/deletion screening of 188 patients with a developmental delay; 162 loci per patient were tested, amounting to over 30 000 typings. The MAPH probes designed for this study can be broadly divided into two groups: (a) subtelomeric and pericentromeric probes (n = 48) and (b) interstitial probes (n = 114), containing sequences located in regions previously found to be rearranged in mentally retarded individuals, and genes randomly spaced through out the genome.
We detected 4.3% (8/184) subtelomeric/pericentromeric rearrangements (six deletions, one duplication, and one subtelomeric deletion/duplication in one patient), using 48 MAPH probes. A subdivision of subtelomeric aberrations over our two study populations agrees with the findings of Knight et al 22 and Yasseen et al. 23 The percentage of subtelomeric mutations detected was higher in a group of MR patients with additional malformations (7.7%) than in a group selected on the basis of developmental delay only (2.5%). This supports the suggestion of De Vries et al that pre-selection of patients for subtelomeric screening is worthwhile. However, pre-selection of these patients for subtelomeric rearrangements is difficult, as only two clinical features (perinatal onset growth retardation and a positive family history) differed significantly between patients with subtelomeric aneusomies and patients with idiopathic MR. 24 Our overall percentage is similar to that reported in a recent paper that summarised all previous subtelomeric publications. 7 A total of 131 subtelomeric imbalances were found using several different methods among 2582 MR patients, resulting in an overall frequency of 5.1%. A review of the corresponding clinical aspects of these subtelomeric rearrangements has been published recently. 25 After re-examining the karyogram of our patients at a banding resolution of 500-550 bands, it showed that five MAPH detected subtelomeric imbalances were not cytogenetically visible, despite the knowledge of a copy number change present. This means that the percentage of ''true'' submicroscopic subtelomeric/ pericentromeric findings is ,3% (5/184) in this study.
Previous reports by Sismani et al 26 and Hollox et al 11 had already shown the ability of MAPH to detect subtelomeric copy number changes. Hollox et al found a copy number change in 5 of 37 male patients (13.5%) who had been referred for fragile X screening. The higher percentage of mutations found by this group may be due to differences in selection criteria for fragile X screening.
We also screened the subtelomeric/pericentromeric regions in eight newborns suffering multiple congenital abnormalities (MCA). Among these patients, one deletion of the subtelomeric region of chromosome 15 was detected and subsequently confirmed by FISH (data not shown). 27 To determine whether it is worthwhile to test this group for submicroscopic mutations, more newborns with MCA should be examined. The ease and relatively low cost of the MAPH technique means that such analysis is feasible. Moreover, new techniques such as MAPH/MLPA and array CGH provide the possibility of genetic diagnosis at a younger age. As the suggestive phenotype for some microdeletion syndromes emerge only later in life, this diagnosis would be very important for providing appropriate healthcare.
In addition to the reports published by Sismani et al 25 and Hollox et al, 11 we also examined interstitially localised genes, including genes involved in several microdeletion syndromes, genes on chromosome 22 (as this was the first chromosome to be completely sequenced), and genes that are spread throughout the genome and might be involved in cognitive development. Recently, Bailey et al 3 argued that regions between highly similar duplications (low copy repeats) are prone to recombination and consequently, copy number changes occur at a higher frequency in these regions compared with other loci in the genome. Several of the areas Figure 3 Facial dysmorphism of case 6. Note the microcephaly, ptosis of the left eye, flat philtrum, and thin upper lip. described were also tested in this study, mostly corresponding to chromosomal reg ions inv olv ed in microdeletion syndromes. I n total, sev en interstitial deletions and duplications were detected, of which f iv e were diag nosed in three dif f erent reg ions k nown to be inv olv ed in the microdeletion syndromes and f lank ed by seg mental duplications. T hree of these interstitial rearrang ements detected include duplications of reg ions that are usually deleted (the chromosome reg ions of S mith M ag enis (1 7 p1 1 .2 ) , D iG eorg e (2 2 q 1 1 .2 ) , and A lag ille syndromes (2 0 p1 2 .2 ) ) . T his observ ation supports the theory that the reg ions between low copy repeats can both be deleted and duplicated, and implies that the number of patients suf f ering f rom a microduplication syndrome is currently probably underestimated. T he phenotype (if any) of a microduplication syndrome mig ht, howev er, be less sev ere, and under standard diag nostic conditions, the detection of duplications is more problematical. I t should be noted that in the second study g roup, the cases with a distinctiv e phenotype f or a specif ic microdeletion syndrome were not included. A s has been the case during the dev elopment of ev ery new techniq ue, the g enomic v ariations detected can be div ided into the f ollowing subclasses: (a) g enetic chang es that are clearly pathog enic, (b) rearrang ements that may or may not be causal to the patient' s problem, and (c) polymorphic chang es. I n some cases, ex tensiv e clinical studies will be needed to determine to which categ ory a newly detected aberration belong s. I n two of our cases, we could detect the rearrang ement in one of the parents (the duplication of chromosome band 1 4 q 1 1 .2 and the deletion of 7 ptel on chromosome band 7 p2 2 .3 ) . O ne ex planation is that these imbalances are polymorphic, and that the phenotype of the patient is not related to the copy number chang e. H owev er, other ex planations are possible: (a) the af f ected reg ion is imprinted, and the parental orig in of this reg ion is critical in causing the deleterious phenotype; 2 8 (b) allelic v ariation in the ex pression of the g enes may inf luence the phenotype; 2 9 and (c) low penetrance of the rearrang ement-that is, a g enetic def ect does not always lead to a phenotypic ef f ect. T he detection of such rearrang ements will increase as hig h resolution techniq ues are applied, and this will pose new problems f or g enetic counselling . T heref ore, it is important to map these f amilial imbalances in f urther detail to allow a g enotype-phenotype correlation in larg er populations of indiv iduals with the same copy number chang e. I n this way, the understanding of any clinical conseq uence of such a rearrang ement should be improv ed. B ased on prev ious publications, sev en rearrang ements f ound in this study were considered to be pathog enic (table 1 ) . I n the remaining cases, the data av ailable in literature were insuf f icient to support a conclusion that the aneusomy detected is related to the phenotype of the patient. I t should be noted that the f act that a rearrang ement is de nov o is not in itself proof that it is causally related to the deleterious phenotype. S ev eral dif f erent metholog ies hav e been described to identif y chang es using M A P H and M L P A . T hese include v isual comparison of traces f rom controls and patients, 3 0 the setting of arbitrary thresholds, 2 6 and biv ariate analysis. 1 1 W e observ ed that the standard dev iations f or each probe v aried slig htly between hybridisations, and could be normalised only within a sing le hybridisation. T he standard dev iation of ' ' normal' ' probes within each patient was calculated, with 3 times this f ig ure def ining the threshold f or a potential rearrang ement, thus minimising the ef f ect of any g enuine copy number chang es on the analysis. A s f alse neg ativ e results are, by def inition, mutations that were not detected, it is dif f icult to determine the percentag e. T o g ain an estimate as to the actual f alse neg ativ e rate, we look ed at a number of samples where a mutation was prev iously k nown. W e tested 3 0 samples that had aberrations at loci corresponding to 3 9 of the probes used. T he appropriate copy number chang es were detected in all cases. U sing the L aP lace f ormula p = (x +1 ) / (n+2 ) to prov ide a f alse neg ativ e rate f rom our data yields an ex pected v alue of ,2 .5 % . T his f ig ure sug g ests that the true f alse neg ativ e rate would be, at least f or the 3 9 probes ex amined, comparable to the 2 % theoretically predicted by H ollox e t al . 1 1 O f course, it would be desirable to test all the probes on k nown mutations in the f uture. T he number of interstitial aneusomies f ound in this report streng thens the arg uments f or g enomewide screening f or copy number chang es in dev elopmentally delayed patients. I n most clinical laboratories, deletions and duplications are detected by F I S H . T his usually f ocuses on only one reg ion per hybridisation, and is theref ore relativ ely slow and ex pensiv e. S ev eral new technolog ies hav e emerg ed that f acilitate larg e scale and g enomewide screening of deletion and duplication mutations. F or g enomewide screening , array C G H currently seems to be the most attractiv e, with recent publications describing screening with approx imately 2 0 0 0 B A C -P A C clones at an av erag e resolution of 1 .5 M b. 3 1 3 2 T his is impressiv e, but inherently means that 9 0 % of the g enome is not screened. I n addition, probes in array C G H are 1 0 0 -2 0 0 k b B A C clones, of ten cov ering more than one g ene and thus able to pick up larg e multi-g ene deletions/ duplications only-that is, those .1 0 0 k b, while it is probable that a sig nif icant proportion of deletion/ duplication mutations are smaller than this. I n contrast, it is possible to detect rearrang ements of only 1 0 0 bp using M A P H and M L P A technolog y. B y applying a hig h resolution method, howev er, the percentag e of the g enome that can be screened using the same number of probes will be much less compared with array C G H . U sing M A P H / M L P A , it is not possible to screen the whole g enome f or copy number chang es at this moment, unless a v ery larg e number of probes are included. F or this reason, a dif f erent approach is req uired. W e consider array C G H to be an ex cellent tool f or f inding larg e reg ions in the g enome where g enes inv olv ed in particular diseases reside. A s soon as these areas hav e been identif ied, targ eted and much cheaper assays can be desig ned, z ooming in on these reg ions only. F or these reasons, we believ e that g ene specif ic screening is ultimately more attractiv e. W ith that in mind, M A P H / M L P A hav e an important role in such analyses, as they are able to pick up both larg e and small deletions/ duplications. a n Om m e n , J T d e n Du n n e n , M H B r e u n i n g , C e n t e r f o r H u m a n a n d C l i n i c a l G e n e t i c s , L e i d e n U n i v e r s i t y M e d i c a l C e n t e r , T h e N e t h e r l a n d s *D e p a r t m e n t o f C l i n i c a l G e n e t i c s , U n i v e r s i t y H o s p i t a l G r o n i n g e n , T h e N e t h e r l a n d s 
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